Cantor Fitzgerald Downgrades uniQure BV (QURE) to Neutral following FDA recommendation

March 2, 2026 10:14 AM EST Send to a Friend
(Updated - March 2, 2026 11:02 AM EST)

Cantor Fitzgerald analyst Kristen Kluska upgraded uniQure BV (NASDAQ: QURE) from ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login